BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16807138)

  • 21. Quantification of illegitimate V(D)J recombinase-mediated mutations in lymphocytes of newborns and adults.
    Scheerer JB; Xi L; Knapp GW; Setzer RW; Bigbee WL; Fuscoe JC
    Mutat Res; 1999 Dec; 431(2):291-303. PubMed ID: 10635995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VDJ recombinase-mediated TCR β locus gene usage and coding joint processing in peripheral T cells during perinatal and pediatric development.
    Murray JM; Messier T; Rivers J; O'Neill JP; Walker VE; Vacek PM; Finette BA
    J Immunol; 2012 Sep; 189(5):2356-64. PubMed ID: 22855706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors.
    Brassesco MS; Montaldi AP; Gras DE; Camparoto ML; Martinez-Rossi NM; Scrideli CA; Tone LG; Sakamoto-Hojo ET
    Mutagenesis; 2009 Mar; 24(2):153-60. PubMed ID: 19028982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of V(D)J recombination.
    Spicuglia S; Franchini DM; Ferrier P
    Curr Opin Immunol; 2006 Apr; 18(2):158-63. PubMed ID: 16459067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in acute lymphoblastic leukemia.
    Randolph TR
    Clin Lab Sci; 2004; 17(4):235-45. PubMed ID: 15559730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular spectra of HPRT deletion mutations in circulating T-lymphocytes in Fanconi anemia patients.
    Laquerbe A; Sala-Trepat M; Vives C; Escarceller M; Papadopoulo D
    Mutat Res; 1999 Dec; 431(2):341-50. PubMed ID: 10635999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia.
    Chowdhury T; Brady HJ
    Blood Cells Mol Dis; 2008; 40(2):192-9. PubMed ID: 17905612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational spectral analysis at the HPRT locus in healthy children.
    Finette BA; Kendall H; Vacek PM
    Mutat Res; 2002 Aug; 505(1-2):27-41. PubMed ID: 12175903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromatin structural elements and chromosomal translocations in leukemia.
    Zhang Y; Rowley JD
    DNA Repair (Amst); 2006 Sep; 5(9-10):1282-97. PubMed ID: 16893685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine mapping of V(D)J recombinase mediated rearrangements in human lymphoid malignancies.
    Halper-Stromberg E; Steranka J; Giraldo-Castillo N; Fuller T; Desiderio S; Burns KH
    BMC Genomics; 2013 Aug; 14():565. PubMed ID: 23957733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SKY reveals a high frequency of unbalanced translocations involving chromosome 6 in t(12;21)-positive acute lymphoblastic leukemia.
    Betts DR; Stanchescu R; Niggli FK; Cohen N; Rechavi G; Amariglio N; Trakhtenbrot L
    Leuk Res; 2008 Jan; 32(1):39-43. PubMed ID: 17418891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias.
    Paulsson K; Jonson T; Ora I; Olofsson T; Panagopoulos I; Johansson B
    Br J Haematol; 2007 Jul; 138(2):196-201. PubMed ID: 17593026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion mutations in the hprt gene of T-lymphocytes as a biomarker for genomic rearrangements important in human cancers.
    Fuscoe JC; Zimmerman LJ; Harrington-Brock K; Moore MM
    Carcinogenesis; 1994 Jul; 15(7):1463-6. PubMed ID: 8033326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rearrangements of chromosome 9 in different hematological neoplasia].
    Andreeva SV; Drozdova VD; Ponochevnaia EV; Kavardakova NV
    Tsitol Genet; 2008; 42(5):72-9. PubMed ID: 19140443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPRT mutations, TCR gene rearrangements, and HTLV-1 integration sites define in vivo T-cell clonal lineages.
    Allegretta M; Ardell SK; Sullivan LM; Jacobson S; Mortreux F; Wattel E; Albertini RJ
    Environ Mol Mutagen; 2005; 45(2-3):326-37. PubMed ID: 15744741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Childhood acute lymphocytic leukemia and perspectives on risk assessment of early-life stage exposures.
    Kim AS; Eastmond DA; Preston RJ
    Mutat Res; 2006; 613(2-3):138-60. PubMed ID: 17049456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acrylamide-induced molecular mutation spectra at HPRT locus in human promyelocytic leukaemia HL-60 and NB4 cell lines.
    Ao L; Liu SX; Yang MS; Fong CC; An H; Cao J
    Mutagenesis; 2008 Jul; 23(4):309-15. PubMed ID: 18407966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting V(D)J recombinase: putting a PHD to work.
    Oltz EM; Osipovich O
    Immunity; 2007 Oct; 27(4):539-41. PubMed ID: 17967406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic mutations at T-cell antigen receptor and glycophorin A loci in pediatric leukemia patients following chemotherapy: comparison with HPRT locus mutation.
    Hirota H; Kubota M; Adachi S; Okuda A; Lin YW; Bessho R; Wakazono Y; Matsubara K; Kuwakado K; Akiyama Y
    Mutat Res; 1994 Sep; 315(2):95-103. PubMed ID: 7521002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.